Adient (NYSE:ADNT) Stock

Adient

Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion.

Ulta Beauty (ULTA)

News

Downgrades

Intraday Update

Analyst Ratings

Trading Ideas

ADNT

GRAB

ULTA

This Ulta Beauty Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

FedEx Corp.

Pre-Market Outlook

Markets

Movers

HAFN

MLKN

RZLV

VEEA

FedEx Reports Downbeat Results, Joins MillerKnoll And Other Big Stocks Moving Lower In Friday&#39;s Pre-Market Session

Earnings

Small Cap

ARCB

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Adient plc (NYSE: ADNT) is an automotive seating supplier. The Zacks Consensus Estimate for its current year earnings has been revised 10.7% downward over the last 60 days.

New Strong Sell Stocks for July 1st

Adient PLC

Offerings

Adient Reports Pricing Of $795M Of 7.50% Senior Unsecured Notes Due 2033

UBS analyst Joseph Spak maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Neutral and raises the price target from $19 to $20.

Price Target

UBS Maintains Neutral on Adient, Raises Price Target to $20

Guidance

Adient Sees FY25 Net Sales Of $13.9B Vs. $14.11B Estimate (Prior View: $14.1B-$14.5B)

Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.20 by 35 percent. This is a 12.9 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $3.495 billion which beat the analyst consensus estimate of $3.422 billion by 2.15 percent. This is a 4.51 percent decrease over sales of $3.660 billion the same period last year.

Earnings Beats

Adient Q1 2025 Adj. EPS $0.27 Beats $0.20 Estimate, Sales $3.495B Beat $3.422B Estimate

<h3>Companies Reporting Before The Bell</h3>
• SAP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) is projected to report quarterly earnings at $1.51 per share on revenue of $9.14 billion. 
• NextEra Energy Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEP#NYSE">NEP</a>) is estimated to report quarterly earnings at $0.50 per share on revenue of $368.65 million. 
• World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) is expected to report quarterly earnings at $1.96 per share on revenue of $131.78 million. 
• Xerox Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRX#NASDAQ">XRX</a>) is expected to report quarterly earnings at $0.49 per share on revenue of $1.58 billion. 
• PACCAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) is estimated to report quarterly earnings at $1.69 per share on revenue of $7.52 billion. 
• Provident Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROV#NASDAQ">PROV</a>) is likely to report quarterly earnings at $0.25 per share on revenue of $9.74 million. 
• BCB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCBP#NASDAQ">BCBP</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $24.64 million. 
• Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) is expected to report quarterly earnings at $1.50 per share on revenue of $4.87 billion. 
• JetBlue Airways (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) is estimated to report quarterly loss at $0.31 per share on revenue of $2.26 billion. 
• Sandy Spring Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SASR#NASDAQ">SASR</a>) is projected to report quarterly earnings at $0.48 per share on revenue of $104.14 million. 
• Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) is likely to report quarterly earnings at $1.49 per share on revenue of $3.77 billion. 
• Invesco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>) is projected to report quarterly earnings at $0.49 per share on revenue of $1.16 billion. 
• Sysco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYY#NYSE">SYY</a>) is estimated to report quarterly earnings at $0.93 per share on revenue of $20.11 billion. 
• Synchrony Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) is projected to report quarterly earnings at $1.90 per share on revenue of $3.84 billion. 
• Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) is projected to report quarterly loss at $1.69 per share on revenue of $17.10 billion. 
• Polaris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.69 billion. 
• CommVault Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) is projected to report quarterly earnings at $0.87 per share on revenue of $245.81 million. 
• RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) is likely to report quarterly earnings at $1.38 per share on revenue of $20.56 billion. 
• Camden National (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAC#NASDAQ">CAC</a>) is likely to report quarterly earnings at $0.88 per share on revenue of $45.23 million. 
• Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) is expected to report quarterly earnings at $0.35 per share on revenue of $3.45 billion. 
• Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) is projected to report quarterly earnings at $6.54 per share on revenue of $18.75 billion. 
• General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) is likely to report quarterly earnings at $1.68 per share on revenue of $41.55 billion. 
• Popular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPOP#NASDAQ">BPOP</a>) is projected to report quarterly earnings at $2.11 per share on revenue of $750.00 million. 
<h3>Companies Reporting After The Bell</h3>
• Alerus Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRS#NASDAQ">ALRS</a>) is projected to report quarterly earnings at $0.28 per share on revenue of $63.09 million. 
• Packaging Corp of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>) is likely to report quarterly earnings at $2.53 per share on revenue of $2.13 billion. 
• Stryker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>) is estimated to report quarterly earnings at $3.87 per share on revenue of $6.36 billion. 
• Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) is estimated to report quarterly earnings at $1.97 per share on revenue of $569.76 million. 
• UMB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UMBF#NASDAQ">UMBF</a>) is expected to report quarterly earnings at $2.26 per share on revenue of $412.27 million. 
• Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) is estimated to report quarterly earnings at $0.68 per share on revenue of $9.32 billion. 
• Trustmark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMK#NASDAQ">TRMK</a>) is estimated to report quarterly earnings at $0.83 per share on revenue of $195.03 million. 
• Veritex Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBTX#NASDAQ">VBTX</a>) is projected to report quarterly earnings at $0.55 per share on revenue of $112.22 million. 
• First Commonwealth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCF#NYSE">FCF</a>) is projected to report quarterly earnings at $0.35 per share on revenue of $119.92 million. 
• Merchants Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIN#NASDAQ">MBIN</a>) is estimated to report quarterly earnings at $1.30 per share on revenue of $158.80 million. 
• F5 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) is estimated to report quarterly earnings at $3.38 per share on revenue of $716.48 million. 
• Primis Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRST#NASDAQ">FRST</a>) is likely to report quarterly earnings at $0.11 per share on revenue of $24.78 million. 
• Houlihan Lokey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLI#NYSE">HLI</a>) is likely to report quarterly earnings at $1.49 per share on revenue of $594.64 million. 
• Hanmi Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAFC#NASDAQ">HAFC</a>) is likely to report quarterly earnings at $0.52 per share on revenue of $61.52 million. 
• Qorvo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) is likely to report quarterly earnings at $1.21 per share on revenue of $910.83 million. 
• Littelfuse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFUS#NASDAQ">LFUS</a>) is estimated to report quarterly earnings at $2.04 per share on revenue of $525.10 million. 
• Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) is likely to report quarterly earnings at $0.64 per share on revenue of $436.27 million. 
• NEXTracker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) is estimated to report quarterly earnings at $0.59 per share on revenue of $647.78 million. 
• Renasant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) is projected to report quarterly earnings at $0.61 per share on revenue of $167.42 million. 
• RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) is likely to report quarterly earnings at $7.09 per share on revenue of $2.99 billion. 
• Logitech International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>) is likely to report quarterly earnings at $1.34 per share on revenue of $1.24 billion. 
• First Busey (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BUSE#NASDAQ">BUSE</a>) is expected to report quarterly earnings at $0.51 per share on revenue of $116.45 million. 
• Provident Finl Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFS#NYSE">PFS</a>) is expected to report quarterly earnings at $0.50 per share on revenue of $210.60 million. 
• LendingClub (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>) is likely to report quarterly earnings at $0.09 per share on revenue of $206.47 million. 
• Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) is likely to report quarterly earnings at $1.06 per share on revenue of $253.56 million. 
• Chubb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) is likely to report quarterly earnings at $5.38 per share on revenue of $10.83 billion. 
• BXP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXP#NYSE">BXP</a>) is likely to report quarterly earnings at $1.80 per share on revenue of $796.14 million. 
• Flushing Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIC#NASDAQ">FFIC</a>) is likely to report quarterly earnings at $0.22 per share on revenue of $45.98 million. 
• Axos Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AX#NYSE">AX</a>) is expected to report quarterly earnings at $1.75 per share on revenue of $303.63 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALRS

BCBP

BPOP

BUSE

CVLT

FFIC

FFIV

FRST

HAFC

JBLU

LFUS

LOGI

MANH

MBIN

PCAR

PROV

QRVO

RNST

SASR

SBUX

TRMK

UMBF

VBTX

WRLD

Earnings Scheduled For January 28, 2025

JP Morgan analyst Ryan Brinkman maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Neutral and lowers the price target from $24 to $21.

JP Morgan Maintains Neutral on Adient, Lowers Price Target to $21

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Adient, revealing an average target of $21.0, a high estimate of $24.00, and a low estimate of $19.00. Experiencing a 17.65% decline, the current average is now lower than the previous average price target of $25.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1737583289_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A comprehensive examination of how financial experts perceive Adient is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dan Levy</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$21.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>John Murphy</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$24.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Adam Jonas</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$19.00</td>
<td>$21.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Adient. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Adient compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Adient's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Adient's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ADNT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Adient analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Discovering Adient: A Closer Look</h2>
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion.
<h3>Unraveling the Financial Story of Adient</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Negative Revenue Trend: Examining Adient's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -4.48% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Adient's net margin excels beyond industry benchmarks, reaching 2.22%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Adient's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.89% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Adient's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.86%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 1.13, Adient faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

4 Analysts Have This To Say About Adient

Barclays analyst Dan Levy maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Equal-Weight and lowers the price target from $24 to $21.

Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $21

In the current market session, Adient Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) price is at $16.88, after a 0.18% spike. However, over the past month, the stock decreased by 12.27%, and in the past year, by 54.25%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1734986712_0.png" alt="Past Year Chart" />

<h3>Adient P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of 22.98 in the Automobile Components industry, Adient Inc. has a higher P/E ratio of 84.25. Shareholders might be inclined to think that Adient Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1734986712_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Price Over Earnings Overview: Adient

WIIM

Adient Plc shares are trading lower. Wells Fargo downgraded its rating on the stock from Overweight to Equal-Weight and lowered its price target from $27 to $20.

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$460.00</td>
<td>$72.1K</td>
<td>7.2K</td>
<td>53.7K</td>
</tr>
<tr>
<td>GME</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$125.00</td>
<td>$32.1K</td>
<td>75.0K</td>
<td>4.1K</td>
</tr>
<tr>
<td>GLBE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$55.00</td>
<td>$57.8K</td>
<td>4.0K</td>
<td>485</td>
</tr>
<tr>
<td>W</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$55.00</td>
<td>$126.8K</td>
<td>543</td>
<td>310</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$200.00</td>
<td>$86.5K</td>
<td>10.2K</td>
<td>180</td>
</tr>
<tr>
<td>ADNT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$20.00</td>
<td>$27.8K</td>
<td>104</td>
<td>107</td>
</tr>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/24/25</td>
<td>$95.00</td>
<td>$30.0K</td>
<td>1</td>
<td>101</td>
</tr>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$280.00</td>
<td>$32.1K</td>
<td>726</td>
<td>20</td>
</tr>
<tr>
<td>TOL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$140.00</td>
<td>$33.2K</td>
<td>25</td>
<td>16</td>
</tr>
<tr>
<td>RH</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/27/24</td>
<td>$377.50</td>
<td>$37.1K</td>
<td>15</td>
<td>15</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we notice a call option sweep that happens to be bullish, expiring in 4 day(s) on December 20, 2024. This event was a transfer of 51 contract(s) at a $460.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $72.1K, with a price of $1416.0 per contract. There were 7249 open contracts at this strike prior to today, and today 53747 contract(s) were bought and sold. 
• For GME (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>), we notice a call option sweep that happens to be bullish, expiring in 32 day(s) on January 17, 2025. This event was a transfer of 1000 contract(s) at a $125.00 strike. This particular call needed to be split into 48 different trades to become filled. The total cost received by the writing party (or parties) was $32.1K, with a price of $32.0 per contract. There were 75014 open contracts at this strike prior to today, and today 4174 contract(s) were bought and sold. 
• For GLBE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>), we notice a call option sweep that happens to be bearish, expiring in 32 day(s) on January 17, 2025. This event was a transfer of 170 contract(s) at a $55.00 strike. This particular call needed to be split into 36 different trades to become filled. The total cost received by the writing party (or parties) was $57.8K, with a price of $340.0 per contract. There were 4035 open contracts at this strike prior to today, and today 485 contract(s) were bought and sold. 
• Regarding W (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>), we observe a put option trade with bearish sentiment. It expires in 396 day(s) on January 16, 2026. Parties traded 86 contract(s) at a $55.00 strike. The total cost received by the writing party (or parties) was $126.8K, with a price of $1475.0 per contract. There were 543 open contracts at this strike prior to today, and today 310 contract(s) were bought and sold. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a call option trade with neutral sentiment. It expires in 186 day(s) on June 20, 2025. Parties traded 20 contract(s) at a $200.00 strike. The total cost received by the writing party (or parties) was $86.5K, with a price of $4329.0 per contract. There were 10226 open contracts at this strike prior to today, and today 180 contract(s) were bought and sold. 
• For ADNT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>), we notice a call option trade that happens to be bearish, expiring in 368 day(s) on December 19, 2025. This event was a transfer of 96 contract(s) at a $20.00 strike. The total cost received by the writing party (or parties) was $27.8K, with a price of $290.0 per contract. There were 104 open contracts at this strike prior to today, and today 107 contract(s) were bought and sold. 
• Regarding SBUX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>), we observe a call option trade with bearish sentiment. It expires in 39 day(s) on January 24, 2025. Parties traded 100 contract(s) at a $95.00 strike. The total cost received by the writing party (or parties) was $30.0K, with a price of $300.0 per contract. There were 1 open contracts at this strike prior to today, and today 101 contract(s) were bought and sold. 
• Regarding MCD (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), we observe a call option trade with bullish sentiment. It expires in 186 day(s) on June 20, 2025. Parties traded 10 contract(s) at a $280.00 strike. The total cost received by the writing party (or parties) was $32.1K, with a price of $3211.0 per contract. There were 726 open contracts at this strike prior to today, and today 20 contract(s) were bought and sold. 
• Regarding TOL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>), we observe a put option trade with bullish sentiment. It expires in 396 day(s) on January 16, 2026. Parties traded 16 contract(s) at a $140.00 strike. The total cost received by the writing party (or parties) was $33.2K, with a price of $2080.0 per contract. There were 25 open contracts at this strike prior to today, and today 16 contract(s) were bought and sold. 
• Regarding RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>), we observe a call option trade with neutral sentiment. It expires in 11 day(s) on December 27, 2024. Parties traded 8 contract(s) at a $377.50 strike. The total cost received by the writing party (or parties) was $37.1K, with a price of $4645.0 per contract. There were 15 open contracts at this strike prior to today, and today 15 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AMZN

GLBE

TSLA

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

Wells Fargo analyst Colin Langan downgrades Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) from Overweight to Equal-Weight and lowers the price target from $27 to $20.

Wells Fargo Downgrades Adient to Equal-Weight, Lowers Price Target to $20

PRTS

Shares of auto supplier stocks are trading lower. Weakness may be in reaction to worse-than-expected November PPI data, which could cloud rate cut outlook.

James Conklin, EVP at Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>), reported an insider sell on December 5, according to a new SEC filing. 
What Happened: Conklin's decision to sell 11,500 shares of Adient was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001670541/000167054124000133//Archives/edgar/data/1670541/000167054124000133/0001670541-24-000133-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The total value of the sale is $232,875.
As of Friday morning, Adient shares are down by 0.36%, currently priced at $19.42.
<h3>All You Need to Know About Adient</h3>
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion.
<h3>Adient: Delving into Financials</h3>
Revenue Challenges: Adient's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -4.48%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: The company shows a low gross margin of 6.88%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Adient's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.918605.
</li>
</ul>
Debt Management: Adient's debt-to-equity ratio stands notably higher than the industry average, reaching 1.13. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Assessing Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: Adient's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 97.45.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 0.12 is lower than the industry average, implying a discounted valuation for Adient's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 4.75, Adient's EV/EBITDA ratio reflects a below-par valuation compared to industry averages signalling undervaluation
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Unmasking the Significance of Insider Transactions</h3>
Emphasizing the importance of a comprehensive approach, considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Important Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001670541">Check Out The Full List Of Adient's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Adient Insider Trades Send A Signal

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>William Blair analyst Dylan Carden downgraded the rating for Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) from Outperform to Market Perform. Ulta Beauty shares closed at $343.26 on Wednesday. <a href="https://www.benzinga.com/quote/ULTA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587e331a5064ed0001730315/ronald-epstein">B of A Securities analyst Ronald Epstein</a> downgraded RBC Bearings Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBC#NYSE">RBC</a>) from Buy to Neutral but raised the price target from $330 to $335. RBC Bearings shares closed at $324.46 on Wednesday. <a href="https://www.benzinga.com/quote/RBC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Janney Montgomery Scott analyst Robert Farnam downgraded The Hartford Financial Services Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THG#NYSE">THG</a>) from Buy to Neutral and announced a $176 price target. Hanover Insurance shares closed at $118.21 on Wednesday. <a href="https://www.benzinga.com/quote/THG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>China Renaissance analyst Yiwen Zhang downgraded the rating for Grab Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) from Buy to Hold and announced a $5.4 price target. Grab Holdings shares closed at $5.66 on Wednesday. <a href="https://www.benzinga.com/quote/PNW/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities analyst John Murphy downgraded Adient plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) from Buy to Neutral and lowered the price target from $30 to $24. Adient shares closed at $19.06 on Wednesday. <a href="https://www.benzinga.com/quote/ADNT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ULTA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="553" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21133434/image-225-1024x553.png" alt="" class="wp-image-659562" style="width:606px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21133434/image-225-1024x553.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21133434/image-225-300x162.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21133434/image-225-768x415.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21133434/image-225.png 1215w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42114009/wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields</a></li>
</ul>

Jian James Huang, EVP at Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>), reported an insider sell on November 20, according to a new SEC filing. 
What Happened: Huang's recent move involves selling 3,017 shares of Adient. This information is documented in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001670541/000167054124000124//Archives/edgar/data/1670541/000167054124000124/0001670541-24-000124-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday. The total value is $59,585.
At Thursday morning, Adient shares are down by 0.94%, trading at $18.88.
<h3>Discovering Adient: A Closer Look</h3>
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment into this new company. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated seating revenue from joint ventures after factoring in the sale was about $3.8 billion in fiscal 2023 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2023 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $15.4 billion and fiscal 2024 is forecast to about $14.6 billion.
<h3>A Deep Dive into Adient's Financials</h3>
Decline in Revenue: Over the 3 months period, Adient faced challenges, resulting in a decline of approximately -4.48% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 6.88%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Adient's EPS reflects a decline, falling below the industry average with a current EPS of 0.918605.
</li>
</ul>
Debt Management: Adient's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.13, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Navigating Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: Adient's current Price to Earnings (P/E) ratio of 95.3 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 0.12 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Adient's EV/EBITDA ratio, lower than industry averages at 4.69, indicates attractively priced shares.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions serve as a piece of the puzzle in investment decisions, rather than the entire picture.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Unlocking the Meaning of Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001670541">Check Out The Full List Of Adient's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Transaction: Jian James Huang Sells $59K Worth Of Adient Shares

B of A Securities analyst John Murphy downgrades Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) from Buy to Neutral and lowers the price target from $30 to $24.

B of A Securities Downgrades Adient to Neutral, Lowers Price Target to $24

Throughout the last three months, 4 analysts have evaluated Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Adient, presenting an average target of $25.0, a high estimate of $30.00, and a low estimate of $19.00. A decline of 11.75% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1731614428_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The analysis of recent analyst actions sheds light on the perception of Adient by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Adam Jonas</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$19.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>John Murphy</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$27.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Edison Yu</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Hold</td>
<td>$24.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Adient. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Adient compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Adient's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Adient's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ADNT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Adient analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Adient</h2>
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment into this new company. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated seating revenue from joint ventures after factoring in the sale was about $3.8 billion in fiscal 2023 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2023 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $15.4 billion and fiscal 2024 is forecast to about $14.6 billion.
<h3>Adient: A Financial Overview</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Adient's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -4.14%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Adient's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 2.22%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Adient's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.89% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Adient's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.86%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Adient's debt-to-equity ratio surpasses industry norms, standing at 1.13. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 4 Analyst Ratings Have To Say About Adient

Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>) with a Underweight and lowers the price target from $21 to $19.

Morgan Stanley Maintains Underweight on Adient, Lowers Price Target to $19

Adient shares are trading higher after the company reported better-than-expected Q4 financial results.

Press Releases

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Adient to discuss Q4 fiscal 2024 financial results on Nov. 8, 2024

Adient enters into joint development agreement with machine integrator and automation company Paslin

Adient reports fourth quarter and full-year 2024 financial results; provides full-year FY2025 outlook

Commodities

Adient, Jaguar Land Rover and Dow develop closed-loop polyurethane foam seats

Adient to discuss Q1 fiscal 2025 financial results on Jan. 28, 2025

Adient reports Q1 financial results; provides update to FY25 outlook

Adient releases its 2024 Sustainability Report

Adient announces intention to offer $795 million of new senior unsecured notes

Adient announces pricing of $795 million of 7.50% senior unsecured notes due 2033

ADMA

AMCX

CHCT

CSWI

CVGW

DELL

EHAB

ERIE

ETSY

HELE

HLNE

INSP

MERC

PGNY

PLTR

RILY

SPGI

TGNA

TGTX

VNOM

VREX

WOLF

ZEUS

Autoliv

American Axle & Manufacturing Holdings, Inc. Common Stock

American Axle & Mfg Hldgs

BorgWarner

Cooper-Standard Holdings Inc. Common Stock

Cooper-Standard Holdings

Dana

Dorman Prods

ECARX Holdings Inc. - Class A Ordinary shares

ECARX Holdings

Fox Factory Hldg

Gentex

Garrett Motion

Holley

Hesai Group - American Depositary Share, each ADS represents one Class B ordinary share

Comments

Adient

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga